Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.27+0.00 (+0.37%)
Close on Nov 18, 2026Market cap $2.89MP/E –Yield –
Gelteq revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was A$165.65K, up 107.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | A$165.65K | +107.5% |
| FY2023 | Jun 30, 2023 | A$79.84K | – |
See a number that looks wrong?